Richmond, VA, June 29, 2022 – Phlow™ Corp. announced today it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of...
Phlow Corp. is pleased to see the release of the Essential Medicines Supply Chain and Manufacturing Resilience Assessment, an action plan developed by the National Forum to Secure America’s Supply Chain for Essential Medicines. Phlow, a U.S.-based essential medicines...
How Nationwide Children’s Hospitals are Addressing Critical Drug Shortages For more than a decade, medicine shortages have been an important and pressing issue for many patients. Unfortunately, children’s hospitals are uniquely impacted by this critical...
US-based supply chains: Strengthening national security and improving public health Phlow’s Chief Business Officer, Dan Hackman, spoke at the US Pharma and Biotech Summit by FT Live in New York on Wed, May 11. Dan discussed US-based supply chains, the importance...
Phlow Enters into Agreements with Virginia Commonwealth University’s Medicines for All Institute, AMPAC Fine Chemicals and Dr. Malcolm Berry, PhD, joins Phlow Team to Provide Industry-Leading Expertise RICHMOND, Va. (March 21, 2022)- Phlow Corp., a U.S.-based...
